Orphalan completed the acquisition of Orphelia Pharma.

Orphalan, a pharmaceutical company, completed the acquisition of Orphelia Pharma, a French pharmaceutical company. Financial terms were not disclosed. “Bringing these complementary companies together marks a significant milestone for both our organizations and for the broader rare-disease patient population. As a long-term lead investor through OCTALFA, I am proud of the journey we have made and excited about the next steps of the combined company," Gilles Alberici, Orphelia Pharma Executive Chairman and Chief Executive Officer.